SARS-CoV-2's high rate of genetic mutation under immune selective pressure: from oropharyngeal B.1.1.7 to intrapulmonary B.1.533 in a vaccinated patient.


Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
May 2022
Historique:
received: 04 12 2021
revised: 11 02 2022
accepted: 19 02 2022
pubmed: 6 3 2022
medline: 29 4 2022
entrez: 5 3 2022
Statut: ppublish

Résumé

This is the case report of an 84-year-old man affected by COVID-19 between the 2 doses of vaccination, with negative exitus. We analyzed nasopharyngeal samples of viral RNA collected during the disease and nasopharyngeal and lung samples collected postmortem by reverse transcription LAMP (RT-LAMP) PCR and Next Generation Sequencing (NGS). NGS results were analyzed with different bioinformatic tools to define virus lineages and the related single-nucleotide polymorphisms (SNPs). Both lung and nasopharyngeal samples tested positive for SARS-CoV-2 on RT-LAMP. Through bioinformatic analysis, 2 viral RNAs from the nasal swabs, which belonged to the B.1.1.7 lineage, and 1 viral RNA from the lung sample, which belonged to the B.1.533 lineage, were identified. This genetic observation suggested that SARS-CoV-2 tends to change under selective pressure. The high mutation rate of ORFa1b, containing a replicase gene, was a biological image of a complex viral survival system.

Identifiants

pubmed: 35247550
pii: S1201-9712(22)00123-0
doi: 10.1016/j.ijid.2022.02.044
pmc: PMC8888350
pii:
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

169-172

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

Références

Pathogens. 2020 Sep 11;9(9):
pubmed: 32932800
Am Rev Respir Dis. 1987 Sep;136(3):730-6
pubmed: 3307572
Diagnostics (Basel). 2021 Jun 24;11(7):
pubmed: 34202678
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Virus Evol. 2021 Jul 30;7(2):veab064
pubmed: 34527285
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
Glob Chall. 2017 Jan 10;1(1):33-46
pubmed: 31565258
Eur Respir J. 2017 Aug 31;50(2):
pubmed: 28860265
Virus Evol. 2021 Sep 29;7(2):veab078
pubmed: 34642605
Genome Med. 2021 Feb 22;13(1):30
pubmed: 33618765
New Microbiol. 2021 Jul;44(3):181-183
pubmed: 34783350

Auteurs

Nicolò Musso (N)

Laboratory of Molecular and Resistant Antibiotic Medical Microbiology (MMAR), Department of Biomedical and Biotechnological Sciences (BIOMETEC), University of Catania, Catania, Italy.

Jessica Giuseppina Maugeri (JG)

ARNAS Garibaldi Hospital, IC Unit Garibaldi Centro, Catania, Italy.

Dafne Bongiorno (D)

Laboratory of Molecular and Resistant Antibiotic Medical Microbiology (MMAR), Department of Biomedical and Biotechnological Sciences (BIOMETEC), University of Catania, Catania, Italy.

Stefano Stracquadanio (S)

Laboratory of Molecular and Resistant Antibiotic Medical Microbiology (MMAR), Department of Biomedical and Biotechnological Sciences (BIOMETEC), University of Catania, Catania, Italy.

Giovanni Bartoloni (G)

ARNAS Garibaldi Hospital, Pathology Unit, Catania, Italy.

Stefania Stefani (S)

Laboratory of Molecular and Resistant Antibiotic Medical Microbiology (MMAR), Department of Biomedical and Biotechnological Sciences (BIOMETEC), University of Catania, Catania, Italy. Electronic address: stefanis@unict.it.

Emanuela Daniela Di Stefano (ED)

ARNAS Garibaldi Hospital, IC Unit Garibaldi Centro, Catania, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH